CoreAgeRx vs FeelGood Meds: Pricing, meds, and policies

Quick verdict: CoreAgeRx is more explicit about flat monthly pricing for semaglutide and tirzepatide while FeelGood Meds emphasizes compounded options with higher starting prices and a branded option. CoreAgeRx vs FeelGood Meds highlights differences in price, medication format, membership and regulatory notes.

Direct comparison: prices and billing

CoreAgeRx advertises semaglutide at $79 / Month and tirzepatide at $129 / Month with a stated promise of “Same Price. Every Month.” The provider says there is No Membership Fee and no billing surprises. FeelGood Meds lists compounded injections starting at $149 / mo, compounded tablets starting at $249 / mo, and a branded option shown from $1,999 / mo. FeelGood Meds also states No membership fee and Free Shipping on the landing page evidence.

See FeelGood Meds starting prices

Medication options and dosing differences

CoreAgeRx lists specific dose ceilings in captured text: tirzepatide up to 7.5 mg and semaglutide up to 1.0 mg. FeelGood Meds presents treatment formats: Compounded injections, compounded tablets, and a branded medication option with variation in starting prices. Both providers indicate treatment is clinician reviewed and available when a licensed clinician determines it is medically appropriate.

Membership, shipping and visit requirements

CoreAgeRx highlights a 3-MINUTE ONLINE VISIT and No Insurance Required, and repeats the claim “Same price every month | No memberships.” FeelGood Meds also states No insurance required, No membership fee and Free Shipping. Both entries advise confirming eligibility, medication, total cost, renewal terms and state availability before enrollment.

Regulatory and compounded medication notes

Both providers include a regulatory note about compounded medications. CoreAgeRx captured text states: “Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.” FeelGood Meds capture states: “Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.” These qualifiers apply where compounded options are offered.

Comparison table at a glance

Patient experience claims and captured testimonials

CoreAgeRx captured text includes a testimonial style claim with specific outcome numbers. FeelGood Meds landing evidence lists multiple weight-loss examples and a “Weight Loss Money Back Guarantee” claim on the captured page. These are presented as provider material on the captured landing pages and should be assessed alongside clinician review requirements.

How the two differ in practice

Price structure: CoreAgeRx emphasizes flat, unchanging monthly pricing for listed branded options. FeelGood Meds emphasizes compounded formats with higher starting prices for injections and tablets and a much higher branded listing. Medication options: CoreAgeRx lists dose limits for named drugs. FeelGood Meds highlights compounded and branded choices. Regulatory transparency: both include the same caution that compounded medications are not FDA-approved and require clinician review.

View FeelGood Meds treatment options

Conclusion and recommendation

CoreAgeRx vs FeelGood Meds boils down to pricing model and medication format. CoreAgeRx shows lower listed monthly prices for its named semaglutide and tirzepatide options and stresses flat monthly pricing with No Membership Fee. FeelGood Meds shows compounded injections and tablets starting at higher monthly prices and lists a branded option that is substantially more expensive.

Choose CoreAgeRx if you prioritize flat monthly pricing for listed semaglutide or tirzepatide options and want pricing that the provider presents as unchanged month to month. Choose FeelGood Meds if you are interested in compounded injections or tablets as presented or want access to a branded option noted on the landing page evidence. In all cases confirm eligibility, medication, total cost, renewal terms and state availability and remember that compounded medications are not FDA-approved when offered.